Anzeige
Mehr »
Montag, 30.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
216 Leser
Artikel bewerten:
(0)

Sectra PACS Wins 'Best in KLAS' in the US for the Sixth Year in a Row

LINKÖPING, Sweden and SHELTON, Connecticut, Jan. 31, 2019 /PRNewswire/ --

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) continues to be the #1 rated PACS and is awarded the prestigious customer satisfaction award 'Best in KLAS'. For the sixth continuous year, Sectra has been named 'Best in KLAS' in the US for PACS (Large Hospital/IDN) with a score of 94 out of a possible 100. The distinction is given by the healthcare IT data and insights company KLAS Research. With an increasing number of VNA customers, Sectra is also included in the report in the VNA Image Archive category*.

"We are dedicated to contributing to improving the effectiveness in healthcare, and happy users are the ultimate proof that Sectra's staff and solutions achieve that in the best possible way. I am thankful and honored to be acknowledged for our top ratings in customer satisfaction," says Dr. Torbjörn Kronander, President and CEO of Sectra.

The first Sectra PACS was installed in 1993 and today, the company has 1,800 installations worldwide. Sectra PACS is an integral part of Sectra's enterprise imaging solution comprising VNA and spans image-intense departments such as radiology, breast imaging, pathology, orthopaedics, and cardiology.

"When we call the help desk, 90% of our problems can be solved by the person who answers the phone. That is very nice. Sectra's staff members are very knowledgeable and jump right in. Support is definitely the best thing with Sectra," says US Analyst/Coordinator, December 2018, KLAS Research**, https://klasresearch.com/comments/sectra-pacs/1814.

"We have had Sectra PACS for many years, and we could not be happier. Our radiologists have seen numerous PACS products, and they feel that Sectra PACS is by far more functional and easier to use than other products. We have radiology technicians who work at other hospitals part-time. They feel that no other system even compares to Sectra PACS," says US Manager, November 2018, KLAS Research**, https://klasresearch.com/comments/sectra-pacs/1814.

Meet Sectra at HIMSS and ECR 2019
Sectra's enterprise imaging solution, including Sectra PACS and Sectra VNA, will be showcased at the HIMSS and ECR trade shows. Visit us at booth #1079 at HIMSS and D11 at ECR to learn more about our solutions.
Book a meeting at HIMSS >>
Book a meeting at ECR >>

About 'Best in KLAS'
2019 Best in KLAS is a recognition of outstanding efforts to help healthcare organizations in their quest to deliver quality patient care. The Best in KLAS designation is awarded only in those software and services market segments that have the broadest operational and clinical impact on healthcare organizations.

* Sectra was included in KLAS' "Below Konfidence category" because fewer than 15 interviews were conducted. KLAS Konfidence is a measure of sample size.

** Selected commentary about Sectra PACS collected 2018. For a complete view, visit www.klasresearch.com and https://klasresearch.com/best-in-klas-ranking/pacs/2019/7-1.

About Sectra Imaging IT Solutions
With more than 25 years of innovation and 1,800 installations, Sectra is a leading global provider of imaging IT solutions that support healthcare in achieving patient-centric care. Sectra offers an enterprise imaging solution comprising PACS for imaging-intense departments (radiology, pathology, cardiology, orthopaedics), VNA, and share and collaborate solutions. Read more about Sectra and why Sectra PACS is "Best in KLAS" for a sixth consecutive year at http://www.sectra.com/medical/.

For further information, please contact:
Dr. Torbjörn Kronander, CEO and President Sectra AB, +46-(0)-705-23-52-27
Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, +46-(0)-708-23-56-10

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/sectra/r/sectra-pacs-wins--best-in-klas--in-the-us-for-the-sixth-year-in-a-row,c2728360

The following files are available for download:

http://news.cision.com/sectra/i/sectra-pacs-wins--best-in-klas--in-the-us-for-the-sixth-year-in-a-row,c2566096

Sectra PACS wins 'Best in KLAS' in the US for the sixth year in a row

© 2019 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.